Different effects of the serotonergic agonists buspirone and sumatriptan on the posterior pituitary hormonal responses to hypoglycemia in humans

@article{Chiodera1996DifferentEO,
  title={Different effects of the serotonergic agonists buspirone and sumatriptan on the posterior pituitary hormonal responses to hypoglycemia in humans},
  author={P. Chiodera and R. Volpi and L. Capretti and G. Caffarri and V. Coiro},
  journal={Neuropeptides},
  year={1996},
  volume={30},
  pages={187-192}
}
  • P. Chiodera, R. Volpi, +2 authors V. Coiro
  • Published 1996
  • Biology, Medicine
  • Neuropeptides
  • The responses of serum oxytocin (OT) and vasopressin (AVP) to the serotonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumatriptan (6 mg injected subcutaneously) were evaluated in 7 normal men either in basal conditions or during an insulin (0.15 iu/kg as an i.v. bolus) tolerance test (ITT). Neither buspirone nor sumatriptan administration modified the basal secretion of AVP and OT. Stimulation of 5HT-1D receptors with sumatriptan was unable to change neither AVP nor OT response… CONTINUE READING
    4 Citations

    Topics from this paper.

    Drugs and Pituitary Function
    • 2
    Forebrain Pathways Mediating Stress-Induced Hormone Secretion
    • 371

    References

    SHOWING 1-10 OF 21 REFERENCES
    Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine.
    • 91
    A Preliminary Neuroendocrine Study with Buspirone in Major Depression
    • 27
    • PDF